Assessment of tumor response, alpha-fetoprotein (AFP) response, and time to progression (TTP) in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC)

Basit Öğe Kaydı
dc.authoridRimassa, Lorenza/0000-0001-9957-3615
dc.authoridCicin, Irfan/0000-0002-7584-3868
dc.authorwosidYau, Thomas Chung Cheung/B-3429-2011
dc.authorwosidRimassa, Lorenza/N-4884-2016
dc.authorwosidCicin, Irfan/AAQ-5575-2020
dc.contributor.authorYau, T.
dc.contributor.authorMerle, P.
dc.contributor.authorRimassa, L.
dc.contributor.authorRyoo, B-Y.
dc.contributor.authorCicin, I.
dc.contributor.authorHarris, W. P.
dc.contributor.authorBanu, E.
dc.date.accessioned2024-06-12T11:24:07Z
dc.date.available2024-06-12T11:24:07Z
dc.date.issued2018
dc.departmentTrakya Üniversitesien_US
dc.descriptionEuropean-Society-for-Medical-Oncology Asia Congress -- NOV 23-25, 2018 -- Singapore, SINGAPOREen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipEuropean Soc Med Oncolen_US
dc.description.sponsorshipExelixis, Inc.en_US
dc.description.sponsorshipExelixis, Inc.en_US
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.urihttps://hdl.handle.net/20.500.14551/26820
dc.identifier.volume29en_US
dc.identifier.wosWOS:000458082200256en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherOxford Univ Pressen_US
dc.relation.ispartofAnnals Of Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleAssessment of tumor response, alpha-fetoprotein (AFP) response, and time to progression (TTP) in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC)en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu